Showing results (191-200 of 432) with videos related to

Sort By:
Pageof 44
Clinical Genitourinary Cancer|June 11, 2019
Cabozantinib in Renal Cell Carcinoma With Brain Metastases: Safety and Efficacy in a Real-World PopulationGiorgia Peverelli, Alessandra Raimondi, Raffaele Ratta, et al.
Tumori|November 6, 2020
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinomaRaffaele Ratta, Elena Verzoni, Alessia Mennitto, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|November 17, 2020
Patient associations and clinical oncology research: how much does a patient's voice really matter?Veronica Franchina, Celeste Cagnazzo, Alessandro Di Costanzo, et al.
Endocrine|December 2, 2016
Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumorsMassimo Milione, Patrick Maisonneuve, Alessio Pellegrinelli, et al.
International Journal of Cancer|December 7, 2018
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)Claudio Vernieri, Sara Pusceddu, Giovanni Fucà, et al.
Breast Cancer (Tokyo, Japan)|January 7, 2017
Complete remission in metastatic breast cancer: expecting the unexpected-results of a cross-sectional studyGiulia Galli, Anna Tessari, Luca Porcu, et al.
Journal of Neuroendocrinology|July 16, 2021
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging noveltiesKetevani Kankava, Patrick Maisonneuve, Alessandro Mangogna, et al.
Cancer Treatment Reviews|June 24, 2020
Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakesMélanie Claps, Alessia Mennitto, Valentina Guadalupi, et al.
Oncology and Therapy|May 1, 2025
Bone Metastases and Skeletal Complications: Information and Involvement of Patients with Cancer in the Treatment PathwayStefania Gori, Alessandra Fabi, Giuseppe Procopio, et al.
Targeted Oncology|August 7, 2026
Impact of PSA Nadir on Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysisMattia Alberto Di Civita, Laura Pappalardo, Danila De Angelis, et al.
Pageof 44